{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:22:24Z","timestamp":1792416144257,"version":"4.4.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Tumor-induced osteomalacia (TIO) is a rare disease that behaves benignly. Very few reports about the features of the responsible tumors according to anatomical locations have been presented.<\/jats:p>\n            <jats:p>In this retrospective study of 53 patients with TIO-associated tumors in the foot\/ankle, tibia and femur, we compared preoperative, postoperative, and follow-up courses, including alkaline phosphatase, phosphorus, and fibroblast growth factor 23, to compare the characteristics of TIO-associated tumors in these 3 locations (level of evidence: therapeutic level III).<\/jats:p>\n            <jats:p>Patients in the foot\/ankle group had longer disease courses and therefore a significantly higher complication rate (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). All TIO-associated tumors in the foot\/ankle group involved soft tissue (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.021), whereas most lesions in the tibia group involved bone, and therefore had much higher concentrations of alkaline phosphatase (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.020). Additionally, serum phosphorus took much longer to normalize after surgery in the foot\/ankle group than that in the other 2 groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.004). Consequently, symptom remission was much better in the tibia and femur groups (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.008). Moreover, the Ki 67 index in TIO-associated tumors was significantly higher in the foot\/ankle group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001) and the recurrence rate in this group was markedly higher (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.002).<\/jats:p>\n            <jats:p>The TIO-associated tumors in the foot\/ankle are characteristically of occult onset, more soft-tissue involvement, and more readily recurrence. More knowledge and examinations are necessary to enable early diagnosis, radical treatments, and minimize recurrence. New therapies are welcomed and needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014846","type":"journal-article","created":{"date-parts":[[2019,3,17]],"date-time":"2019-03-17T11:46:07Z","timestamp":1552823167000},"page":"e14846","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of surgical treatments of tumor-induced osteomalacia in different locations in the lower limbs"],"prefix":"10.1097","volume":"98","author":[{"given":"Ye","family":"Li","sequence":"first","affiliation":[{"name":"Department of Orthopedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking Union Medical College Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Orthopedics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Orthopedics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0300-2977(01)00095-X","article-title":"Medical problems in mineral metabolism. 1936","volume":"58","author":"McCance","year":"2001","journal-title":"Neth J Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM197007092830204","article-title":"Hypophosphatemic osteomalacia associated with \u201cnonendocrine\u201d tumors","volume":"283","author":"Salassa","year":"1970","journal-title":"N Engl J Med"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1523-1755.2005.00506.x","article-title":"Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules","volume":"68","author":"Baum","year":"2005","journal-title":"Kidney Int"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00198-017-4007-2","article-title":"Tumor-induced osteomalacia: experience from a South American academic center","volume":"28","author":"Gonz\u00e1lez","year":"2017","journal-title":"Osteoporos Int"},{"key":"R6-20230914","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2009.04.141","article-title":"Hyperaminoaciduria and resolving phosphaturia in a family with autosomal dominant hypophosphataemic rickets (ADHR) due to a mutation in the FGF23 gene","author":"Koehle","year":"2009","journal-title":"Bone"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia--a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1521-690X(03)00055-1","article-title":"Disorders of phosphate metabolism--pathomechanisms and management of hypophosphataemic disorders","volume":"17","author":"Ritz","year":"2003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12957-015-0589-3","article-title":"En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review","volume":"13","author":"Meng","year":"2015","journal-title":"World J Surg Oncol"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12020-011-9512-z","article-title":"Evaluation of bone markers in hypophosphatemic rickets\/osteomalacia","volume":"40","author":"Nagata","year":"2011","journal-title":"Endocrine"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","article-title":"Nomogram for derivation of renal threshold phosphate concentration","volume":"2","author":"Walton","year":"1975","journal-title":"Lancet"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/adc.57.3.217","article-title":"Renal threshold phosphate concentration (TmPO4\/GFR)","volume":"57","author":"Kruse","year":"1982","journal-title":"Arch Dis Child"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","article-title":"Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients","volume":"42","author":"Endo","year":"2008","journal-title":"Bone"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00041552-200207000-00003","article-title":"Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin","volume":"11","author":"Fukumoto","year":"2002","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.lpm.2010.10.011","article-title":"Curative surgical treatment after inefficient long-acting somatostatin analogues therapy of a tumor-induced osteomalacia","volume":"40","author":"Mekinian","year":"2011","journal-title":"Presse Med"},{"key":"R19-20230914","first-page":"90","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of Surgical Complications","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies","volume":"12","author":"Shane","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bonr.2017.09.002","article-title":"Tumor-induced osteomalacia","volume":"7","author":"Florenzano","year":"2017","journal-title":"Bone Rep"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","article-title":"Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET\/CT","volume":"98","author":"Cliftonbligh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","article-title":"Tumor localization and biochemical response to cure in tumor-induced osteomalacia","volume":"28","author":"Chong","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","article-title":"(68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia","volume":"101","author":"Elmaouche","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","article-title":"68 Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111 in-octreotide SPECT\/CT","volume":"64","author":"Breer","year":"2014","journal-title":"Bone"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jcp.20494","article-title":"Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells","volume":"206","author":"Bullwinkel","year":"2005","journal-title":"J Cell Physiol"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2559.1990.tb00788.x","article-title":"Monoclonal antibody Ki-67: its use in histopathology","volume":"17","author":"Brown","year":"1990","journal-title":"Histopathology"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00285178","article-title":"Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10","volume":"83","author":"Schonk","year":"1989","journal-title":"Hum Genet"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/excr.2000.4888","article-title":"The Ki-67 protein: fascinating forms and an unknown function","volume":"257","author":"Endl","year":"2000","journal-title":"Exp Cell Res"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature18610","article-title":"Ki-67 acts as a biological surfactant to disperse mitotic chromosomes","volume":"535","author":"Cuylen","year":"2016","journal-title":"Nature"},{"key":"R35-20230914","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/24699322.2017.1282044","article-title":"Three-dimensional fluoroscopic navigation-assisted surgery for tumors in patients with tumor-induced osteomalacia in the bones","volume":"22","author":"Kobayashi","year":"2017","journal-title":"Comput Assist Surg (Abingdon)"},{"key":"R36-20230914","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","article-title":"Selective venous catheterization for the localization of phosphaturic mesenchymal tumors","volume":"26","author":"Andreopoulou","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R37-20230914","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/jbmr.3219","article-title":"Multimodality image-guided cryoablation for inoperable tumor-induced osteomalacia","volume":"32","author":"Tella","year":"2017","journal-title":"J Bone Miner Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:52:35Z","timestamp":1694728355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903150-00063"}},"subtitle":["A retrospective study"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014846","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}